Furthermore, we predicted the binding site of ARHGEF12 and found that CUR might inhibit the invasion and migration of colon cancer cells by inhibiting the binding of ARHGEF12 to RhoA. This evidence concerns the gene RHOA and malignant colon neoplasm.